Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 229 (LINC00229) is a human long non-coding RNA (lncRNA) gene located on chromosome 22 (gene symbol: LINC00229)[1][3][7][5]. It does not encode a protein product and is classified as a non-coding RNA gene. There are no well-established or widely studied biological functions, disease associations, or roles as a therapeutic target reported for LINC00229[1][3][7][5]. It is also referred to by aliases such as C22orf10, NCRNA00229, and dJ474I12.C22.2. There is currently no evidence linking LINC00229 to clinical biomarkers, interacting drugs, or mechanisms of drug action. It is primarily catalogued in genomic resources as a long intergenic non-protein coding RNA, and its physiological or pathological roles remain largely uncharacterized.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 229 (LINC00229).